ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,333, issued on Sept. 2, was assigned to REMEGEN Co. LTD. (Shandong, China).
"Anti PD-L1 antibody and use thereof" was invented by Jianmin Fang (Shandong, China), Jing Jiang (Shandong, China), Shenjun Li (Shandong, China) and Guorui Zhao (Shandong, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present invention is a PD-L1 immunosuppressant, and specifically provided are a monoclonal antibody capable of targeting PD-L1, and nucleotides, combinations of polynucleotides, expression vectors and combinations of expression vectors encoding the antibody. Also provided in the present invention is a conjugate or pharmaceutical compositi...